F2 and atrial fibrillation: Data on rFVIIa use were available for 18 minor procedures treated with rFVIIa, rFVIIa + AF, or rFVIIa + PT ± AF; 100% of treatments were rated effective for rFVIIa (6/6) and rFVIIa + AF (6/6), and 83.3% (5/6) of treatments were rated effective for rFVIIa + PT ± AF (Table 2A).